In preclinical researches, certain ligands of TNF receptor have come to exploring as underlying treatment targets in epilepsy, while it is still under controversy whether the therapeutics against epilepsy targeting TNF-α signaling may generate the serious risks of infection and tumorigenesis (59). The gene discussed is TNF; the disease is epilepsy.